Citation Impact

Citing Papers

Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
2016 StandoutScience
Tumor-specific Th17-polarized cells eradicate large established melanoma
2008
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
2011
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
2015
Hallmarks of Cancer: The Next Generation
2011 Standout
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Modulation of interleukin-18 expression in human colon carcinoma: Consequences for tumor immune surveillance
1999
Interleukin-17 family and IL-17 receptors
2003
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
2008 StandoutNature
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Swords into plowshares: IL-23 repurposes tumor immune surveillance
2007
Interleukin-17 Family Members and Inflammation
2004 Standout
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
2000 Standout
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
A Novel Cytokine Receptor-Ligand Pair
2000
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients
2009
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Interleukin-17 promotes angiogenesis and tumor growth
2002
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
2007 StandoutNature
IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo
2009
Th17 cells in cancer: help or hindrance?
2011
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Adoptive immunotherapy of cancer using CD4+ T cells
2009
Immune surveillance of tumors
2007
Inflammation: Gearing the journey to cancer
2008
Psoriasis
2015 Standout
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Inflammatory cell infiltration of tumors: Jekyll or Hyde
2007
Immune infiltration in human tumors: a prognostic factor that should not be ignored
2009
Variable gene family usage of protective and non‐protective anti‐Vibrio cholerae O1 LPS antibody heavy chains
2008
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Immunity, Inflammation, and Cancer
2010 Standout
The Accumulation and Prognosis Value of Tumor Infiltrating IL-17 Producing Cells in Esophageal Squamous Cell Carcinoma
2011
IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1
2001
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
Interleukin‐17 in rheumatoid arthritis: If T cells were to contribute to inflammation and destruction through synergy
2003
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Tumor microenvironment is multifaceted
2011
Functional Specialization of Interleukin-17 Family Members
2011 Standout
Co-receptors for HIV-1 entry
1997
A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage
2007
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
2013
Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis
2006
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
2009
Interleukin-17: a mediator of inflammatory responses
2004
Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
2009
Cancer-related inflammation
2008 StandoutNature
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
2008 StandoutNature
TH17 cells in tumour immunity and immunotherapy
2010
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
2014 Standout
Structure of the Mammalian Ribosomal 43S Preinitiation Complex Bound to the Scanning Factor DHX29
2013 StandoutNobel
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Interleukin-17 Orchestrates the Granulocyte Influx into Airways after Allergen Inhalation in a Mouse Model of Allergic Asthma
2003
Endogenous IL-17 contributes to reduced tumor growth and metastasis
2009
IL-28 Elicits Antitumor Responses against Murine Fibrosarcoma
2007
The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function
1996
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures
2008
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
2012
Secretion of beta-chemokines by bronchoalveolar lavage cells during primary infection of macaques inoculated with attenuated nef-deleted or pathogenic simian immunodeficiency virus strain mac251.
1999
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis
2009
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
2009
IL-17 Enhances the Net Angiogenic Activity and In Vivo Growth of Human Non-Small Cell Lung Cancer in SCID Mice through Promoting CXCR-2-Dependent Angiogenesis
2005
Cutting Edge: IL-17D, a Novel Member of the IL-17 Family, Stimulates Cytokine Production and Inhibits Hemopoiesis
2002
Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursors
2007 StandoutNobel
Cytokines in Cancer Immunotherapy
2011
CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
2014
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Adverse functions of IL‐17A in experimental sepsis
2008
Cutting Edge: Roles of Toll-Like Receptor 4 and IL-23 in IL-17 Expression in Response toKlebsiella pneumoniaeInfection
2003
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis
2007 StandoutNobel

Works of Alain Gey being referenced

Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma
2016
The Soluble α Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer
2008
Prognostic Value of Intratumoral Interferon Gamma Messenger RNA Expression in Invasive Cervical Carcinomas
1998
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
2017
PCR-based analysis of the murine immunoglobulin heavy-chain repertoire
1995
Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.
1999
Interleukin-17 inhibits tumor cell growth by means of a T-cell–dependent mechanism
2002
Macrophage inflammatory protein-1alpha is induced by human immunodeficiency virus infection of monocyte-derived macrophages
1996
Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma.
1994
Rankless by CCL
2026